Instil Bio Net Income
| TIL Stock | USD 7.09 0.12 1.66% |
As of the 4th of February, Instil Bio retains the Standard Deviation of 7.07, market risk adjusted performance of (1.89), and Risk Adjusted Performance of (0.10). Concerning fundamental indicators, the technical analysis model lets you check existing technical drivers of Instil Bio, as well as the relationship between them. Please check out Instil Bio market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Instil Bio is priced fairly, providing market reflects its last-minute price of 7.09 per share. Given that Instil Bio has information ratio of (0.16), we strongly advise you to confirm Instil Bio's regular market performance to make sure the company can sustain itself at a future point.
Instil Bio's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Instil Bio's valuation are provided below:There are over one hundred nineteen available fundamental trends for Instil Bio, which can be analyzed over time and compared to other ratios. We recommend to confirm Instil Bio's regular fundamental drivers against the all of the trends between 2010 and 2026. The value of Market Cap is estimated to slide to about 135.8 M. The Enterprise Value is projected to slide to about 221.1 M This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Loss | -66.7 M | -70.1 M | |
| Net Loss | -141.1 M | -134.1 M | |
| Net Loss | -66.7 M | -70.1 M | |
| Net Loss | (13.10) | (13.75) | |
| Net Income Per E B T | 1.14 | 1.10 |
Instil | Net Income | Build AI portfolio with Instil Stock |
Historical Net Income data for Instil Bio serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Instil Bio represents a compelling investment opportunity.
Latest Instil Bio's Net Income Growth Pattern
Below is the plot of the Net Income of Instil Bio over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Instil Bio financial statement analysis. It represents the amount of money remaining after all of Instil Bio operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Instil Bio's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Instil Bio's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (74.14 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Instil Net Income Regression Statistics
| Arithmetic Mean | (49,955,887) | |
| Coefficient Of Variation | (135.24) | |
| Mean Deviation | 52,616,089 | |
| Median | (6,454,000) | |
| Standard Deviation | 67,558,753 | |
| Sample Variance | 4564.2T | |
| Range | 216.7M | |
| R-Value | (0.63) | |
| Mean Square Error | 2906.2T | |
| R-Squared | 0.40 | |
| Significance | 0.01 | |
| Slope | (8,493,706) | |
| Total Sum of Squares | 73027T |
Instil Net Income History
Other Fundumenentals of Instil Bio
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Instil Bio Net Income component correlations
Instil Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Instil Bio is extremely important. It helps to project a fair market value of Instil Stock properly, considering its historical fundamentals such as Net Income. Since Instil Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Instil Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Instil Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instil Bio. If investors know Instil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Instil Bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Instil Bio's market price often diverges from its book value, the accounting figure shown on Instil's balance sheet. Smart investors calculate Instil Bio's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Instil Bio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Instil Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Instil Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Instil Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Instil Bio.
| 11/06/2025 |
| 02/04/2026 |
If you would invest 0.00 in Instil Bio on November 6, 2025 and sell it all today you would earn a total of 0.00 from holding Instil Bio or generate 0.0% return on investment in Instil Bio over 90 days. Instil Bio is related to or competes with Zentalis Pharmaceuticals, Surrozen, Pliant Therapeutics, Oncolytics Biotech, Atossa Genetics, Whitehawk Therapeutics, and MacroGenics. Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with canc... More
Instil Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Instil Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Instil Bio upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 55.58 | |||
| Value At Risk | (9.97) | |||
| Potential Upside | 6.59 |
Instil Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Instil Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Instil Bio's standard deviation. In reality, there are many statistical measures that can use Instil Bio historical prices to predict the future Instil Bio's volatility.| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (1.09) | |||
| Total Risk Alpha | (1.48) | |||
| Treynor Ratio | (1.90) |
Instil Bio February 4, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.10) | |||
| Market Risk Adjusted Performance | (1.89) | |||
| Mean Deviation | 3.95 | |||
| Coefficient Of Variation | (667.53) | |||
| Standard Deviation | 7.07 | |||
| Variance | 49.95 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (1.09) | |||
| Total Risk Alpha | (1.48) | |||
| Treynor Ratio | (1.90) | |||
| Maximum Drawdown | 55.58 | |||
| Value At Risk | (9.97) | |||
| Potential Upside | 6.59 | |||
| Skewness | (3.95) | |||
| Kurtosis | 24.5 |
Instil Bio Backtested Returns
Instil Bio holds Efficiency (Sharpe) Ratio of -0.12, which attests that the entity had a -0.12 % return per unit of risk over the last 3 months. Instil Bio exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Instil Bio's Risk Adjusted Performance of (0.10), market risk adjusted performance of (1.89), and Standard Deviation of 7.07 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.56, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Instil Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Instil Bio is expected to be smaller as well. At this point, Instil Bio has a negative expected return of -0.9%. Please make sure to check out Instil Bio's value at risk, daily balance of power, as well as the relationship between the Daily Balance Of Power and period momentum indicator , to decide if Instil Bio performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.86 |
Very good predictability
Instil Bio has very good predictability. Overlapping area represents the amount of predictability between Instil Bio time series from 6th of November 2025 to 21st of December 2025 and 21st of December 2025 to 4th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Instil Bio price movement. The serial correlation of 0.86 indicates that approximately 86.0% of current Instil Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.86 | |
| Spearman Rank Test | 0.77 | |
| Residual Average | 0.0 | |
| Price Variance | 3.79 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Instil Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Instil Bio reported net income of (74.14 Million). This is 121.72% lower than that of the Biotechnology sector and 205.84% lower than that of the Health Care industry. The net income for all United States stocks is 112.98% higher than that of the company.
Instil Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Instil Bio's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Instil Bio could also be used in its relative valuation, which is a method of valuing Instil Bio by comparing valuation metrics of similar companies.Instil Bio is currently under evaluation in net income category among its peers.
Instil Bio Current Valuation Drivers
We derive many important indicators used in calculating different scores of Instil Bio from analyzing Instil Bio's financial statements. These drivers represent accounts that assess Instil Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Instil Bio's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Enterprise Value | 3.1B | 1.8B | 126.4M | 202.4M | 232.7M | 221.1M |
Instil Bio ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Instil Bio's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Instil Bio's managers, analysts, and investors.Environmental | Governance | Social |
Instil Bio Institutional Holders
Institutional Holdings refers to the ownership stake in Instil Bio that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Instil Bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Instil Bio's value.| Shares | Boxer Capital Management, Llc | 2025-06-30 | 70.7 K | Renaissance Technologies Corp | 2025-06-30 | 70.7 K | Northern Trust Corp | 2025-06-30 | 64.4 K | Assenagon Asset Management Sa | 2025-06-30 | 57.5 K | Blackrock Inc | 2025-06-30 | 50.7 K | Macquarie Group Ltd | 2025-06-30 | 50 K | Geode Capital Management, Llc | 2025-06-30 | 43.1 K | State Street Corp | 2025-06-30 | 17.6 K | Trexquant Investment Lp | 2025-06-30 | 17.4 K | Bml Capital Management Llc | 2025-06-30 | 534.9 K | Cpmg Inc | 2025-06-30 | 410.9 K |
Instil Fundamentals
| Return On Equity | -0.51 | ||||
| Return On Asset | -0.15 | ||||
| Current Valuation | 54.08 M | ||||
| Shares Outstanding | 6.78 M | ||||
| Shares Owned By Insiders | 6.29 % | ||||
| Shares Owned By Institutions | 67.91 % | ||||
| Number Of Shares Shorted | 490.48 K | ||||
| Price To Earning | 18.31 X | ||||
| Price To Book | 0.40 X | ||||
| Price To Sales | 55,330 X | ||||
| Gross Profit | 138 K | ||||
| EBITDA | (62.53 M) | ||||
| Net Income | (74.14 M) | ||||
| Cash And Equivalents | 354.61 M | ||||
| Cash Per Share | 2.73 X | ||||
| Total Debt | 86.89 M | ||||
| Debt To Equity | 0.12 % | ||||
| Current Ratio | 8.51 X | ||||
| Book Value Per Share | 17.76 X | ||||
| Cash Flow From Operations | (55.7 M) | ||||
| Short Ratio | 2.04 X | ||||
| Earnings Per Share | (11.35) X | ||||
| Target Price | 29.0 | ||||
| Number Of Employees | 14 | ||||
| Beta | 2.1 | ||||
| Market Capitalization | 48.9 M | ||||
| Total Asset | 263.57 M | ||||
| Retained Earnings | (655.12 M) | ||||
| Working Capital | 116.57 M | ||||
| Net Asset | 263.57 M |
About Instil Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Instil Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Instil Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Instil Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instil Bio. If investors know Instil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Instil Bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Instil Bio's market price often diverges from its book value, the accounting figure shown on Instil's balance sheet. Smart investors calculate Instil Bio's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Instil Bio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Instil Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.